![Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2020/02/New-Project-20-1-1.jpg)
Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners
![Les fonds conseillés par Motion Equity Partners annoncent la signature de l'acquisition du Laboratoire Equilibre Attitude - Motion Equity Partners Les fonds conseillés par Motion Equity Partners annoncent la signature de l'acquisition du Laboratoire Equilibre Attitude - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2018/12/EA-Pharma-brands-vf.png)
Les fonds conseillés par Motion Equity Partners annoncent la signature de l'acquisition du Laboratoire Equilibre Attitude - Motion Equity Partners
![EA Pharma poursuit son expansion européenne avec l'acquisition de la marque italienne Stardea - Motion Equity Partners EA Pharma poursuit son expansion européenne avec l'acquisition de la marque italienne Stardea - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2022/07/New-Project-1-1.jpg)